Clinical Trial Update: Daridorexant to Prevent Delirium After Heart Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial tested daridorexant for preventing postoperative delirium and postoperative cognitive decline after heart surgery; the study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Decline
• Postoperative Delirium

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: University of Rochester | Conditions: POSTOPERATIVE DELIRIUM, POSTOPERATIVE COGNITIVE DECLINE | Phase 2 | Status: COMPLETED | Results posted: 2025-07-11